Best for
All-rounder
How to buy Mereo BioPharma Group shares | 31p
Own Mereo BioPharma Group shares in just a few minutes.
Mereo BioPharma Group plc is a biotechnology business based in the UK. Mereo BioPharma Group shares (MPH.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 31p – a decrease of 8.01% over the previous week. Mereo BioPharma Group employs 50 staff and has a market cap (total outstanding shares value) of £89.8 million.
How to buy shares in Mereo BioPharma Group
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: MPH in this case.
- Research Mereo BioPharma Group shares. The platform should provide the latest information available.
- Buy your Mereo BioPharma Group shares. It's that simple.
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
What's in this guide?
- Can I buy shares in Mereo BioPharma Group?
- Has coronavirus impacted Mereo BioPharma Group shares?
- Mereo BioPharma Group shares summary
- Compare share dealing platforms
- Is Mereo BioPharma Group stock a buy or sell?
- Mereo BioPharma Group performance over time
- Mereo BioPharma Group's financials
- How volatile are Mereo BioPharma Group shares?
- Does Mereo BioPharma Group pay a dividend?
- Other common questions
How has Coronavirus impacted Mereo BioPharma Group's share price?
Since the stock market crash in March caused by coronavirus, Mereo BioPharma Group's share price has had significant positive movement.
Its last market close was 31p, which is 0.00% up on its pre-crash value of 31p and 138.46% up on the lowest point reached during the March crash when the shares fell as low as 13p.
If you had bought £1,000 worth of Mereo BioPharma Group shares at the start of February 2020, those shares would have been worth £666.67 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,148.15.
Mereo BioPharma Group share price
Use our graph to track the performance of MPH stocks over time.Mereo BioPharma Group shares at a glance
Information last updated 2020-12-26.
| Latest market close | 31p |
|---|---|
| 52-week range | 16p - 60p |
| 50-day moving average | 32p |
| 200-day moving average | 40.837p |
| Wall St. target price | 705p |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | -43p |
Invest in Mereo BioPharma Group shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Mereo BioPharma Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Mereo BioPharma Group price performance over time
Historical closes compared with the last close of 29.5p
| 1 month (2020-12-17) | 12.60% |
|---|---|
| 3 months (2020-10-16) | -18.06% |
| 6 months (2020-07-17) | -34.66% |
| 1 year (2020-01-17) | -7.81% |
|---|---|
| 2 years (2019-01-17) | -83.66% |
| 3 years (2018-01-17) | -90.87% |
Mereo BioPharma Group financials
| Gross profit TTM | £0 |
|---|---|
| Return on assets TTM | -20.81% |
| Return on equity TTM | -344.02% |
| Profit margin | 0% |
| Book value | 0.072p |
| Market capitalisation | £89.8 million |
TTM: trailing 12 months
Mereo BioPharma Group share dividends
We're not expecting Mereo BioPharma Group to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Mereo BioPharma Group share price volatility
Over the last 12 months, Mereo BioPharma Group's shares have ranged in value from as little as 16p up to 60p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Mereo BioPharma Group's is 0.7463. This would suggest that Mereo BioPharma Group's shares are less volatile than average (for this exchange).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Mereo BioPharma Group overview
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company also develops Navicixizumab (OMP-305B83) that is in Phase 1a clinical trial for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that has completed Phase II clinical trial to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody, which is in Phase IIb clinical trial for the treatment of osteogenesis imperfect; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. Mereo BioPharma Group plc was founded in 2015 and is based in London, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Mereo BioPharma Group shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
-
How to buy Van Elle Holdings shares | 42p
Ever wondered how to buy shares in Van Elle Holdings? We explain how and compare a range of providers that can give you access to many brands, including Van Elle Holdings.
-
How to buy ULS Technology shares | 80.7p
Ever wondered how to buy shares in ULS Technology? We explain how and compare a range of providers that can give you access to many brands, including ULS Technology.
Ask an Expert